Analyst InsightsBiotech StocksStock NewsYahooFinance Capricor (CAPR) Shares Could Hit $10, Says Analyst Investors of micro-cap biotech Capricor (CAPR) were probably raising a glass or two last week, as the stock skyrocketed by 253% in one … Marty Shtrubel, May 6, 2020
Analyst InsightsBiotech Stocks This Penny Stock Joins the Fight Against Coronavirus; Analyst Sees Triple-Digit Upside With a market cap of a miniscule $10.16 million, you can firmly place biotech Capricor Therapeutics (CAPR) in the nano cap section. Marty Shtrubel, April 6, 2020
Biotech Stocks Capricor Therapeutics Inc (CAPR) Announces Q4 2017 Operating Results and Corporate Update Capricor Therapeutics Inc (NASDAQ:CAPR) reported its fourth quarter and full year 2017 financial results. It also provided a corporate update. Smarter Team, March 14, 2018
Biotech StocksStock News Capricor Therapeutics Inc (CAPR) Shares Soar on Back of FDA Investigational New Drug Clearance Brace yourself. Capricor Therapeutics Inc (NASDAQ:CAPR) is on the move. Corey Williams, November 29, 2017
Biotech StocksStock News Capricor Therapeutics Inc (CAPR) Shares Climb Ahead of the American Heart Association (AHA) Scientific Sessions 2017 US-based biotechnology firm Capricor Therapeutics Inc (NASDAQ:CAPR) announced that the American Heart Association (AHA) Scientific Sessions 2017 has accepted for presentation at a late-breaking session the … Corey Williams, October 25, 2017
Biotech StocksLong Ideas Capricor Therapeutics Inc (CAPR) Investors Throw Bullish Parade After H.C. Wainwright Boosts Price Target Analyst spotlights a compelling path forward for DMD program and looks to key catalysts in fourth quarter. Julie Lamb, September 15, 2017
Biotech StocksLong Ideas Rodman and Renshaw Sings the Praises of Capricor Therapeutics, Inc. (CAPR); Here’s Why On Tuesday, Capricor Therapeutics, Inc. (NASDAQ:CAPR) was granted FDA Rare Pediatric Disease Designation for CAP-1002, the company’s treatment for Duchenne muscular dystrophy (DMD) and … Joe Rabin, Editor, July 19, 2017
Bloggers CornerExclusive Tuesday’s Wall Street News: Netflix, Inc. (NFLX), Capricor Therapeutics Inc (CAPR), Moleculin Biotech Inc (MBRX) Netflix, Inc. (NASDAQ:NFLX) shares are shooting up in Tuesday’s trading session following the release of very impressive earnings results for the second quarter. Harriet Lefton, July 18, 2017
Biotech StocksMost PopularStock News Capricor Therapeutics Inc (CAPR) Shares Skyrocket – Here’s Why It’s a very rewarding trading day for investors in Capricor Therapeutics Inc (NASDAQ:CAPR) with shares up nearly 130%, making the stock Wall Street’s … Corey Williams, July 18, 2017
Analyst InsightsBiotech StocksExclusively PublishedInsights H.C. Wainwright Reiterates Buy On Capricor Following 3Q14 Results In a research note issued today, H.C. Editor Ben Weinberg, November 13, 2014
